{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T05:38:20Z","timestamp":1772775500199,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001102","name":"Cancer Council NSW","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jhep.2020.08.038","type":"journal-article","created":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T11:05:36Z","timestamp":1599908736000},"page":"293-302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["High hepatitis C treatment uptake among people with recent drug dependence in New South Wales, Australia"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8608-2558","authenticated-orcid":false,"given":"Heather","family":"Valerio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Law","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shane","family":"Tillakeratne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janaki","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveed Z.","family":"Janjua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mel","family":"Krajden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8421-5476","authenticated-orcid":false,"given":"Jacob","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail V.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2212-2028","authenticated-orcid":false,"given":"Behzad","family":"Hajarizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8513-2218","authenticated-orcid":false,"given":"Louisa","family":"Degenhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1833-2017","authenticated-orcid":false,"given":"Jason","family":"Grebely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4741-2622","authenticated-orcid":false,"given":"Gregory J.","family":"Dore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2020.08.038_bib1","series-title":"Global Health Sector Strategy on Viral Hepatitis 2016-2021. Towards Ending Viral Hepatitis","year":"2016"},{"key":"10.1016\/j.jhep.2020.08.038_bib2","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1093\/infdis\/jis928","article-title":"Breaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV\/HIV coinfection: action required at the system, provider, and patient levels","volume":"207","author":"Grebely","year":"2013","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jhep.2020.08.038_bib3","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.jhep.2018.06.016","article-title":"The removal of DAA restrictions in Europe\u2013one step closer to eliminating HCV as a major public health threat","volume":"69","author":"Marshall","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.038_bib4","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/liv.14324","article-title":"Global timing of hepatitis C virus elimination in high-income countries","volume":"40","author":"Razavi","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2020.08.038_bib5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/COH.0000000000000179","article-title":"The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM): the use of direct-acting antivirals as treatment for prevention","volume":"10","author":"Martin","year":"2015","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.jhep.2020.08.038_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/jvh.13013","article-title":"Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: a modelling study","volume":"26","author":"Kwon","year":"2019","journal-title":"J\u00a0viral Hepat"},{"key":"10.1016\/j.jhep.2020.08.038_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jhep.2018.09.030","article-title":"Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia","volume":"70","author":"Iversen","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.038_bib8","first-page":"ciaa571","article-title":"Progress towards elimination of hepatitis C infection among people who inject drugs in Australia: the ETHOS Engage Study","author":"Valerio","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2020.08.038_bib9","series-title":"HIV, viral hepatitis and sexually transmissible infections in Australia: Annual Surveillance Report 2018","year":"2018"},{"key":"10.1016\/j.jhep.2020.08.038_bib10","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1186\/s12889-017-4785-7","article-title":"Estimating the number of people who inject drugs in Australia","volume":"17","author":"Larney","year":"2017","journal-title":"BMC public health"},{"key":"10.1016\/j.jhep.2020.08.038_bib11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jhep.2019.04.014","article-title":"Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia","volume":"71","author":"Alavi","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.038_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.drugpo.2018.02.001","article-title":"Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets","volume":"55","author":"Janjua","year":"2018","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.jhep.2020.08.038_bib13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJMcp1204714","article-title":"Alcohol use in adults","volume":"368","author":"Friedmann","year":"2013","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jhep.2020.08.038_bib14","series-title":"Improved Reporting of Aboriginal and Torres Strait Islander Peoples on Population Datasets in New South Wales Using Record Linkage\u2013A Feasibility Study","year":"2012"},{"key":"10.1016\/j.jhep.2020.08.038_bib15","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1111\/liv.14227","article-title":"The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: impact of direct acting antivirals","volume":"39","author":"Bartlett","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2020.08.038_bib16","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/joim.12740","article-title":"Treatment as Prevention for Hepatitis C (TraP Hep C)\u2013a nationwide elimination programme in Iceland using direct-acting antiviral agents","volume":"283","author":"\u00d3lafsson","year":"2018","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jhep.2020.08.038_bib17","doi-asserted-by":"crossref","first-page":"637","DOI":"10.15585\/mmwr.mm6829a2","article-title":"Progress in testing for and treatment of hepatitis C virus infection among persons who inject drugs\u2014Georgia, 2018","volume":"68","author":"Stvilia","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jhep.2020.08.038_bib18","doi-asserted-by":"crossref","first-page":"e029538","DOI":"10.1136\/bmjopen-2019-029538","article-title":"Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe)\u2013a natural experiment (protocol)","volume":"9","author":"Hickman","year":"2019","journal-title":"BMJ open"},{"key":"10.1016\/j.jhep.2020.08.038_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-7517-10-7","article-title":"Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors","volume":"10","author":"Harris","year":"2013","journal-title":"Harm reduction J"},{"key":"10.1016\/j.jhep.2020.08.038_bib20","doi-asserted-by":"crossref","first-page":"e25051","DOI":"10.1002\/jia2.25051","article-title":"Linkage and retention in HCV care for HIV-infected populations: early data from the DAA era","volume":"21","author":"Sacks-Davis","year":"2018","journal-title":"J\u00a0Int AIDS Soc"},{"key":"10.1016\/j.jhep.2020.08.038_bib21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"EASL Recommendations on treatment of Hepatitis C 2018","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2020.08.038_bib22","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/hep.31060","article-title":"Hepatitis C guidance 2019 update: American Association for the Study of Liver Diseases\u2013Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection","volume":"71","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.038_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jcv.2016.02.026","article-title":"Direct-acting antiviral treatment in adults infected with hepatitis C virus: Reactivation of hepatitis B virus coinfection as a further challenge","volume":"78","author":"De Monte","year":"2016","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.jhep.2020.08.038_bib24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12954-018-0209-y","article-title":"Evaluation of the Deadly Liver Mob program: insights for roll-out and scale-up of a pilot program to engage Aboriginal Australians in hepatitis C and sexual health education, screening, and care","volume":"15","author":"Treloar","year":"2018","journal-title":"Harm reduction J"},{"key":"10.1016\/j.jhep.2020.08.038_bib25","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jhep.2016.08.010","article-title":"Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000\u20132014)","volume":"65","author":"Waziry","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.038_bib26","series-title":"The Health of Australia's Prisoners 2018. Cat. no. PHE 246","year":"2019"},{"key":"10.1016\/j.jhep.2020.08.038_bib27","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jhep.2016.04.029","article-title":"Treatment of alcohol use disorders in patients with alcoholic liver disease","volume":"65","author":"Addolorato","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.038_bib28","series-title":"Monitoring Hepatitis C Treatment Uptake in Australia (Issue 10)","year":"2019"},{"key":"10.1016\/j.jhep.2020.08.038_bib29","series-title":"Australian NSP Survey: Prevalence of HIV, HCV and Injecting and Sexual Behaviour Among NSP Attendees, 25-Year National Data Report 1995-2019","author":"Heard","year":"2020"},{"key":"10.1016\/j.jhep.2020.08.038_bib30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugpo.2017.07.006","article-title":"Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade","volume":"47","author":"Scott","year":"2017","journal-title":"Int J Drug Policy"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820336187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820336187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:39:50Z","timestamp":1759174790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827820336187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0168827820336187"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2020.08.038","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High hepatitis C treatment uptake among people with recent drug dependence in New South Wales, Australia","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2020.08.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}